No Pharma Money
All News & Reports

News

The week in prescription drug pricing: what moved, what it means for patients, and what comes next.

Stay Up To Date

News and reports from P4ADNow

News Mar 3, 2021

Oregon Patient Testifies in Support of Penalizing Big Pharma for Abusive “Pay-For-Delay” Deals

Oregon patient advocate Michael Nielsen will testify in front of the Oregon Senate Committee on Health Care today in support of Senate Bill 764, which cracks down on abusive “pay-for-delay” deals…

Read Article
News Mar 1, 2021

The Week in Review in Prescription Drug Pricing

Patients For Affordable Drugs turned 4 years old this week! Thank you to everyone who has been in this fight with us.

Read Article
News Feb 24, 2021

Following Becerra Commitments To Take On Drug Prices, Patients For Affordable Drugs Now Urges Swift Confirmation By The Senate

The following statement was issued today by David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs Now:

Read Article
News Feb 22, 2021

The Week in Review in Prescription Drug Pricing

Who would’ve thought we’d land on Mars EIGHT TIMES before we landed lower drug prices?

Read Article
News Feb 19, 2021

There is something very wrong with the American health care system.

My name is Kirk and I live in Bowling Green, Kentucky. I’m 52 years old and am self-employed. I’ve worked hard and enjoyed being productive my entire adult life.

Read Article
News Feb 16, 2021

Minnesota Patient Testifies in Support of Creating a State Affordability Board

Hamrin lives with multiple myeloma, an incurable blood cancer, and relies on Revlimid, an oral chemotherapy drug sold by Celgene/Bristol Myers Squibb, to keep her alive.

Read Article
News Feb 15, 2021

The Week in Review in Prescription Drug Pricing

On Thursday, the Maryland House of Delegates joined the State Senate in establishing permanent funding for the first-in-the-nation prescription drug affordability board.

Read Article
News Feb 8, 2021

New Mexico Patient Testifies in Support of Creating a State Drug Affordability Board

Albuquerque patient Kristina Caffrey will share her story of relying on a $350,000-a-year prescription medication with the state House Health and Human Services committee today.

Read Article
News Feb 8, 2021

The Week in Review in Prescription Drug Pricing

Ahead of Super Bowl Sunday, here’s a reminder that Humira generates more in revenue than these two teams AND ALL THE OTHERS COMBINED.

Read Article
News Feb 1, 2021

The Week in Review in Prescription Drug Pricing

This isn’t a GAME. STOP gouging prescription drug prices, pharma. Welcome to the Week in Review.

Read Article

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.